NeoVas Bioresorbable Coronary Scaffold Registry Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 825 participants.

Also called NCT02305472

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 825 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02305472
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02305472. Allocation not applicable; no masking; primary purpose treatment. Start 2014-11 (registry gives no type); primary completion 2017-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
NeoVas Bioresorbable Coronary Scaffold Registry Study
Intervention (Device)
NeoVas BCS
Lead sponsor
Lepu Medical Technology (Beijing) Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct02305472
Content hash
b7ca46cfdc5052ee501fc32f79182b50de782cc68a0c300e82c87b6a531c5083